The ESMO Congress is one of the world’s leading oncology meetings, bringing together clinicians, researchers, industry leaders, and policymakers to share the latest advances in cancer research, clinical development, precision medicine, and biomarker-driven treatment strategies. The congress serves as a key platform for presenting practice-changing data and engaging with the global oncology community.

AIDA plans to attend ESMO to engage with clinical and industry stakeholders, follow developments in precision oncology, and explore opportunities for scientific exchange and collaboration.